ArticleCellular and molecular life sciences : CMLS2024

Dapagliflozin targets SGLT2/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells.

Long Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.